CEO Bender also noted progress in the clinical pipeline, including the FIREFLY-2 confirmatory trial, which is on track to be fully enrolled by the first half of 2026. Additionally, the DAY301 program ...

Recraft, known for its benchmark-beating AI image model tailored for brands, has raised $30M in a Series B round led by Accel ...